Loading…
RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system
Objective Recent, more selective use of radioactive iodine (RAI) has led to reevaluation of the clinical importance of achieving complete total thyroidectomy with minimal residual normal thyroid tissue. We utilize the improved localization by post‐RAI remnant ablation, single photon emission compute...
Saved in:
Published in: | The Laryngoscope 2015-10, Vol.125 (10), p.2417-2424 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
Recent, more selective use of radioactive iodine (RAI) has led to reevaluation of the clinical importance of achieving complete total thyroidectomy with minimal residual normal thyroid tissue. We utilize the improved localization by post‐RAI remnant ablation, single photon emission computerized tomography‐computed tomography (SPECT‐CT) to define specific anatomic sites of residual RAI‐uptake foci after total thyroidectomy for differentiated thyroid cancer (DTC) and to provide a novel classification system relating uptake to thyroid anatomy and preservation of adjacent neural structures.
Study Design
Retrospective.
Method
Radioactive iodine‐uptake foci in thyroid bed were localized by SPECT/CT imaging at the time of RAI remnant ablation in 141 DTC patients undergoing total thyroidectomy.
Results
Minimal residual RAI uptake (median 0.32% at 24 hours) in the thyroid bed was detected by diagnostic planar whole body scans in 93% and by posttherapy SPECT/CT imaging in 99% of subjects. Discrete RAI uptake foci were identified on the SPECT/CT imaging at Berry's ligament (87%), at superior thyroid poles (79%), in paratracheal‐lobar regions (67%), in isthmus‐region (54%), and in pyramidal lobe (46%). Despite the residual foci, the nonstimulated thyroglobulin (Tg) prior to remnant ablation (with a median thyroid‐stimulating hormone of 0.36 m IU/L) was |
---|---|
ISSN: | 0023-852X 1531-4995 |
DOI: | 10.1002/lary.25295 |